Brief: Moberg Pharma: OncoZenge Gets Conditional Approval For Listing On Nasdaq First North Growth Market

Moberg Pharma AB (publ)

08/02/2021 10:02

Feb 8 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * ONCOZENGE HAS OBTAINED A CONDITIONAL APPROVAL FOR LISTING
ON
NASDAQ FIRST NORTH GROWTH MARKET AND PUBLISHES PROSPECTUS
    * FIRST DAY OF TRADING IN ONCOZENGE'S SHARES IS EXPECTED TO
BE
FEBRUARY 12, 2021

Source text for Eikon:  ID:nWkr2znYj7 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))